SEC Form 4 · accession 0001209191-15-032244
AMEDISYS INC · AMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael O. Fleming
Officer — Chief Medical Officer
Period of report
Apr 1, 2015
Accepted (ET)
Apr 3, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 1, 2015 | F | 1,468 | $27.45 | D | 19,452 | D | |
| Common StockF1 | Apr 1, 2015 | A | 500 | $0.00 | A | 19,952 | D | |
| Common StockF2 | holding | — | — | — | 1,155 | I | Through 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares awarded are subject to service-based vesting conditions as follows: 33.33% of the total shares granted will vest on April 1, 2016, 33.33% of the total shares granted will vest on April 1, 2017 and 33.33% of the total shares granted will vest on April 1, 2018, provided that the reporting person remains continuously employed by the issuer through each such date.
- F2Includes 195 shares acquired under the issuer's 401(k) plan since the date of the reporting person's last ownership report.